CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma

Ecto-5′-nucleotidase (CD73) is a membrane-bound enzyme, which catalyzes the conversion of adenosine monophosphate to adenosine. CD73 has been postulated to play an important role in carcinogenesis, as adenosine promotes tumor progression and CD73-expressing cancer cell lines are more aggressive. However, other studies have shown that activated adenosine receptors may also inhibit cell proliferation. This study investigated the clinical significance of CD73 expression in breast cancer. The study group included 136 consecutive stage I-III breast cancer patients treated between 2001 and 2008 at 2 institutions. CD73 expression was examined by immunohistochemistry (IHC) on tissue microarrays, using antihuman mouse monoclonal antibody. Survival curves were generated by the Kaplan-Meier method and compared using the log-rank test. CD73 staining was expressed as the score calculated by multiplying the staining intensity (0=negative, 1=weak, 2=intermediate, 3=strong) and percentage of positive cells (0% to 100%). The median score among all samples was 100. Positive CD73 staining (defined as score equal or higher than 100) occurred in 74% of the cases. No correlation was found between CD73 expression and grading, tumor size, lymph node status, histologic type, estrogen receptor, or progesterone receptor status. Positive CD73 expression strongly correlated with longer disease-free survival (hazard ratio=0.26; 95% confidence interval, 0.1-0.66; P=0.0044) and overall survival (hazard ratio =0.24; 95% confidence interval, 0.07-0.85; P=0.027). Multivariate analysis for disease-free survival revealed correlation with tumor size and CD73 status. Elevated CD73 expression in breast cancer can predict a good prognosis. However, the actual role of CD73 in cancerogenesis remains unclear and requires further analysis.

[1]  C. Barrios,et al.  Differential ectonucleotidase expression in human bladder cancer cell lines. , 2010, Urologic oncology.

[2]  Ole N Jensen,et al.  Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[3]  A. Delgado-Cañedo,et al.  The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation , 2008, Molecular and Cellular Biochemistry.

[4]  Z. Ou,et al.  Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells , 2008, Journal of Cancer Research and Clinical Oncology.

[5]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[6]  Z. Ou,et al.  Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo. , 2007, Oncology reports.

[7]  A. Składanowski,et al.  Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma , 2006, Melanoma research.

[8]  David M. Conrad,et al.  Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor. , 2005, Experimental and molecular pathology.

[9]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[10]  T. Nishizaki,et al.  Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. , 2004, Biochemical pharmacology.

[11]  B. Mitchell,et al.  Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer , 2004, Clinical Cancer Research.

[12]  M. Bissell,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[13]  J. Spychała.  Tumor-promoting functions of adenosine. , 2000, Pharmacology & therapeutics.

[14]  D. Przywara,et al.  Adenosine induces apoptosis by inhibiting mRNA and protein synthesis in chick embryonic sympathetic neurons , 1998, Neuroscience Letters.

[15]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[17]  P. Möller,et al.  Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma. , 1991, British Journal of Cancer.

[18]  T. D. Hamilton,et al.  Classification of Tumours , 1930, Edinburgh medical journal.

[19]  R. Çetin,et al.  Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues , 2005, Breast Cancer Research and Treatment.